LSI Emerging Medtech Summit Will Spotlight 100 Innovative Startups to Audience of Investors & Strategic Partners
LAGUNA NIGUEL, Calif.--(BUSINESS WIRE)--Feb 12, 2020--
Life Science Intelligence (LSI) is hosting the Emerging Medtech Summit February 18-20 th, 2020 at The Ritz-Carlton in Laguna Niguel, CA. The event is drawing attendance from major medtech investors and strategics looking to partner with new medical device, diagnostic, digital health and other healthtech innovators.
In addition to startup CEO presentations, the event will include panel discussions on timely industry topics with venture capitalists, large corporates, and industry thought leaders.
Registration will close on February 15 th or sooner and attendance is limited. Registration and full program details are here.
Investors attending: JJDC, Sante Ventures, Connecticut Innovations, US Venture Partners, NEA, Pangaea Ventures, SV Health Investors, Miraki Innovation Fund, MVM Partners, Evonik VC, Sands Capital, Mayo Clinic Ventures, HealthTech Capital, Grey Sky Venture Partners, and more.
Strategics attending: J&J, Medtronic, Boston Scientific, Edwards Lifesciences, Terumo, Fresenius, Intuitive Surgical, BD, W.L. Gore, and more.
Startup presenting companies:
About Life Science Intelligence (LSI)
LSI is a medical technology focused market intelligence & consulting company. We help medtech executives make informed strategic decisions by better understanding market dynamics, trends, opportunities and the competitive landscape.
View source version on businesswire.com:https://www.businesswire.com/news/home/20200212005906/en/
CONTACT: Maricela Almonte
Life Science Intelligence
714 847 3540 Tel
KEYWORD: CALIFORNIA UNITED STATES NORTH AMERICA
INDUSTRY KEYWORD: BIOTECHNOLOGY HEALTH OTHER HEALTH MEDICAL DEVICES
SOURCE: Life Science Intelligence
Copyright Business Wire 2020.
PUB: 02/12/2020 04:34 PM/DISC: 02/12/2020 04:34 PM